OncoLens Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 6

OncoLens General Information

Description

Developer of a HIPAA-compliant mobile and web-based platform designed for targeted treatment planning and confident clinical decision-making. The company's platform brings disparate data sets, oncology care teams, and stakeholders into a singular platform to drive multi-disciplinary treatment planning, life-science commercial and clinical efforts, and payor authorizations enhanced by its AI-driven clinical decision support capabilities, enabling the physicians to create a tumor board and discuss treatment plans for cancer patients.

Contact Information

Website
www.oncolens.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Atlanta Technology Development Center, Georgia Tech
  • 75 5th Street North West
  • Atlanta, GA 30308
  • United States
+1 (404) 000-0000
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Vertical(s)
SaaS, Artificial Intelligence & Machine Learning, HealthTech, Oncology
Corporate Office
  • Atlanta Technology Development Center, Georgia Tech
  • 75 5th Street North West
  • Atlanta, GA 30308
  • United States
+1 (404) 000-0000

OncoLens Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoLens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 30-Mar-2023 $2.5M 000.00 Completed Generating Revenue
4. Secondary Transaction - Private 01-Dec-2021 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 13-Jan-2021 00.000 00.000 000.00 Completed Generating Revenue
2. Seed Round 26-Mar-2019 $750K $750K 00.000 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2017 Completed Startup
To view OncoLens’s complete valuation and funding history, request access »

OncoLens Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series A-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed-1 1,740,139 $0.001000 7% $0.43 $0.43 1x $0.43 8.17%
To view OncoLens’s complete cap table history, request access »

OncoLens Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a HIPAA-compliant mobile and web-based platform designed for targeted treatment planning and confident clin
Decision/Risk Analysis
Atlanta, GA
40 As of 2024
000.00
0000000000 0 000.00

0000 0

llamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
00000 0000000000 000
Columbus, OH
00 As of 0000
000.00
000000&0 000.00

000000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labo
0000000000000 000000
Cambridge, MA
00 As of 0000
000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoLens Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Deep Lens Formerly VC-backed Columbus, OH 00 000.00 000000&0 000.00
GenoSpace Corporate Backed or Acquired Cambridge, MA 00 000 000000&0
PierianDx Private Equity-Backed Creve Coeur, MO 000 000.00 000000000000 000.00
InterpretOmics Formerly VC-backed Bangalore, India 00.000 00000000000 00.000
Genomenon Venture Capital-Backed Ann Arbor, MI 000 000.00 00000000000 000.00
You’re viewing 5 of 11 competitors. Get the full list »

OncoLens Executive Team (8)

Name Title Board Seat
Anju Mathew Co-Founder, Chief Executive Officer & Board Member
Heather Creran Chief Operating Officer
Jane McCracken Advisor
Kishore Kumar Advisor
Timothy Mullett Advisor
You’re viewing 5 of 8 executive team members. Get the full list »

OncoLens Board Members (8)

Name Representing Role Since
Anju Mathew OncoLens Co-Founder, Chief Executive Officer & Board Member 000 0000
Devin Carty Self Board Member 000 0000
Lijo Simpson OncoLens Co-Founder, Chief Medical Officer & Board Member 000 0000
Mark Buffington BIP Ventures Board Member 000 0000
Shantanu Nigam SeedToB Capital Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

OncoLens Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoLens Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cross Border Impact Ventures Impact Investing Minority 000 0000 000000 0
Martin Ventures Venture Capital Minority 000 0000 000000 0
SeedToB Capital Venture Capital Minority 000 0000 000000 0
Atlanta Technology Angels Angel Group Minority 000 0000 000000 0
BIP Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

OncoLens FAQs

  • When was OncoLens founded?

    OncoLens was founded in 2017.

  • Who is the founder of OncoLens?

    Anju Mathew and Lijo Simpson are the founders of OncoLens.

  • Who is the CEO of OncoLens?

    Anju Mathew is the CEO of OncoLens.

  • Where is OncoLens headquartered?

    OncoLens is headquartered in Atlanta, GA.

  • What is the size of OncoLens?

    OncoLens has 40 total employees.

  • What industry is OncoLens in?

    OncoLens’s primary industry is Decision/Risk Analysis.

  • Is OncoLens a private or public company?

    OncoLens is a Private company.

  • What is OncoLens’s current revenue?

    The current revenue for OncoLens is 00000.

  • How much funding has OncoLens raised over time?

    OncoLens has raised $10.5M.

  • Who are OncoLens’s investors?

    Cross Border Impact Ventures, Martin Ventures, SeedToB Capital, Atlanta Technology Angels, and BIP Ventures are 5 of 6 investors who have invested in OncoLens.

  • Who are OncoLens’s competitors?

    Deep Lens, GenoSpace, PierianDx, InterpretOmics, and Genomenon are some of the 11 competitors of OncoLens.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »